The Problem with Peer Review
The Half-Life of the Truth
Some Drug Trials Resume after Declines During Pandemic
More Money, More Research: Foundation Report Sheds Light on Funding Gaps
Influential Lancet Article on HCQ Retracted
Finding Opportunity Through Challenge: Q&A with Vaneet K. Sandhu, MD, FACR, RhMSUS
COVID-19 Pandemic Leads Big Drugmakers to Hit Pause on Clinical Trials
The Third Choice: The Predatory Journal Scam
Emerging Biomarkers for Lupus
- 1
- 2
- 3
- …
- 66
- Next Page »